The RoosterBank™-hUC-1M-XF contains 5 (K40101) or 10 (K40102) vials of 1M xeno-free cryopreserved hUC-MSCs (C43001UC, RoosterVial™-hUC-1M-XF) isolated from the perivascular Wharton’s Jelly region of the human umbilical cord and manufactured with cGMP compatible processes. RoosterBanks allow for consistent starting material across multiple experiments and eliminate the cost and time associated with cell banking, thus accelerating the experimental and product development timelines. Each produced lot is released based on hMSC identity (cell surface marker expression), expansion potential, sterility, and differentiation potential and provided QC brief contains industry-leading functional characterization (immunomodulatory potential (IDO assay), angiogenic cytokine secretion), giving added confidence in quality, reproducibility, and ease of integration.
When used as a complete hUC-MSC bioprocessing system along with RBI’s 2D Batch or 3D Bioreactor Fed-Batch process recommendations and RoosterNourish™-MSC-XF each vial can produce > 500 million high-quality hMSCs within 8 -10 days – giving added confidence in quality, reproducibility, and ease of integration while “Radically Simplifying” your hUC-MSC Product Development.
*RoosterVial-hUC-XF manufactured and sold by RoosterBio, INC and supported by licensed technology from Tissue Regeneration Therapeutics Inc. (TRT) core technology and patent family: US 8,790,923; US 8,278,102; US 7,547,546; US 9,611,456; US 9,611,456; US 8,481,311; US 9,611,456.
Intended Use: Research Use Only
Product Features
Each RoosterBank™ comes with 5 or 10 vials of 1 million xeno-free hUC-MSCs
> 20 fold expansion in 4 to 5 days when cultured with our RoosterNourish™-MSC-XF bioprocess media
Always run experiments with MSCs from the same donor and at a consistent PDL
Manufactured with the same cGMP compatible processes as 10M vial (C43002UC)
1st in class CofA and QC Brief with lot-specific functional hMSC characterization (identity, trilineage differentiation, immunomodulatory potential, and angiogenic cytokine secretion)
RoosterVial™-hUC-1M-XF (xeno-free, C43001UC) cultured in RoosterNourish™-MSC-XF (KT-016) have a fibroblastic cell morphology (left) and express hMSC cell surface markers (right).
Immunomodulatory activity (left, IDO activity increase in response to IFN-y) and angiogenic cytokine secretion (right) of a representative RoosterVial™-hUC-1M-XF (C43001UC) lot.
Trilineage differentiation of a representative RoosterVial™-hUC-1M-XF (C43001UC) cell lot. Adipogenesis, left; Osteogenesis, middle (macro and 100x, for Ca2+ deposition); Chondrogenesis, right.
